TipRanks
Protalix Biotherapeutics (DE:PBDA)
FRANKFURT:PBDA

Compare Protalix (PBDA) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Protalix
€2.20
€191.33M
11.45
29.28%
1 Buy
0 Hold
0 Sell
Moderate Buy
Coherus Biosciences
$1.37
$182.31M
-1.19
-26.22%
4 Buy
0 Hold
0 Sell
Strong Buy
SELLAS Life Sciences Group
$14.09
$2.32B
-58.26
664.60%
2 Buy
0 Hold
0 Sell
Moderate Buy
Protara Therapeutics
$3.91
$189.70M
-2.24
-29.89%
3 Buy
0 Hold
0 Sell
Strong Buy
Innate Pharma
$2.27
$173.10M
-2.75
-15.54%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:PBDA
Protalix
2.34
0.37
18.78%
CHRS
Coherus Biosciences
1.21
-0.41
-25.31%
SLS
SELLAS Life Sciences Group
12.31
10.62
628.40%
TARA
Protara Therapeutics
3.05
-1.36
-30.84%
FBRX
―
―
―
―
IPHA
Innate Pharma
1.63
-0.35
-17.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts